United States Vaccine Market Report 2021: Focus on COVID-19, Flu, Adult, Children, Adolescent and Travel Vaccines – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “2021 Vaccine Market Report” has been added to ResearchAndMarkets.com’s offering.
The U.S. vaccine market is estimated to grow to $25 billion by 2024 with the COVID-19 vaccine market adding $10 billion annually.
New investigational approaches in vaccine research show great promise to expand the vaccine market and treat numerous infectious diseases while utilization of current vaccines increases. The 2021 Vaccine Market Report analyzes major market trends impacting the vaccine industry and discusses key vaccines already in the market including COVID-19, flu, adult, children, adolescent and travel vaccines.
Key points include:
- New vaccines cost $200-500 million to develop
- 11% more flu vaccines were distributed during the 2020-2021 flu season than the previous season
- An estimated 9 million childhood vaccine doses were missed in 2020 due to the pandemic
Key Topics Covered:
- Executive Summary
- Vaccine Market Overview
- The Four Main Vaccine Categories (Or Classifications)
- Nucleic Acid Vaccines Being Investigated For Future Use
- COVID-19 Vaccines Receive First EUAs Using mRNA
- Global Cancer Vaccine Market Expected To Grow To $24.3 Billion By 2030
- New Vaccines Cost $200-500 Million To Develop
- Insurance Or Government Programs Cover Most Recommended Vaccines
- 2021 Global COVID-19 Vaccine Market Valued At $40 Billion
- Many Americans Hesitant To Receive COVID-19 Vaccine
- U.S. Influenza Vaccine Market Estimated To Reach $8.6 Billion By 2027
- 2020-2021 Flu Season Has Lowest Infection Rate Since 2005
- U.S. Pediatric Vaccine Market Projected To Exceed $15 Billion By 2027
- Children’s Vaccination Rates Decline During COVID-19
- Childhood Vaccination Rates Growing Fastest For Flu And Rotavirus
- Global HPV Market Worth $3.3 Billion; Meningococcal Vaccine Market $1.9 Billion
- Adults Require Additional Vaccines As The Immune System Weakens With Age
- 76% Of Adults 85 Or Older Vaccinated Against Pneumonia
- U.S. 2021 Shingles Vaccine Market Estimated At $1 Billion
- Global Travel Vaccine Market Expected To Reach $8.1 Billion By 2024
- 95% Of Hospital Workers Received A Flu Vaccine In 2018-2019
- Appendices
For more information about this report visit https://www.researchandmarkets.com/r/56jrgo
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900